Bringing the fundamentals into focus…
Back to Starling Oncology Inc
How Starling Oncology Inc stacks up
TOI · against 462 other Healthcare companies of similar size
Valuation
8/ 100
Near the bottom of its peers.
Ranked #300 of 463 · scores higher than 12% of peers
Bars: peers in each 10-point band of the valuation score164 peers with a valuation score of 0–9, including TOI · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -4.4% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -6.8% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -0.6% vs peer median 0.0%
Metric by metric
Position: dot = TOI, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TOI | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 451 reported | -6.8% | 0.5% | 30% | 30% | |
| EBITDA yieldHigher is better · 468 reported | -4.4% | 3.6% | 25% | 50% | |
| Free cash flow yieldHigher is better · 201 reported | -0.6% | -7.1% | 66% | 20% | |
| Book yieldHigher is better · 460 reported | -3.2% | 48.4% | 4% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around TOI| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 6.50T IDR (≈$403M) | 99 | 69 | |
| 300 | 549M USD | 8 | 30 | |
| 300 | 976M USD | 8 | 36 | |
| 300 | 371M USD | 8 | ||
| 300 | 394M USD | 8 | 37 | |
| 300 | 513M USD | 8 | 31 | |
| 300 | 289M USD | 8 | ||
| 300 | 522M USD | 8 | 12 | |
| 300 | 885M USD | 8 | 33 | |
| 300 | 595M USD | 8 | 29 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score